Hutchin Hill Capital’s Syneron Medical Ltd ELOS Stock Holding History

Hutchin Hill Capital’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-216,600	Closed	-$2.29M	–	1192
2017 Q1	$2.29M	Buy	216,600 +185,900	+606%	+$1.8M	0.06%	303
2016 Q4	$258K	Buy	+30,700	New	+$241K	0.01%	656
2015 Q2	–	Sell	-28,800	Closed	-$357K	–	895
2015 Q1	$357K	Buy	+28,800	New	+$319K	0.01%	576

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Hutchin Hill Capital's ELOS Position: Q2 2017 in Review

Hutchin Hill Capital sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 216,600 shares — an estimated $2.29M sold.

Hutchin Hill Capital first reported a position in ELOS in Q1 2015 and held it in 3 quarters. The position peaked at $2.29M in Q1 2017. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

Hutchin Hill Capital reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
Hutchin Hill Capital sold 216,600 Syneron Medical Ltd shares in Q2 2017, an estimated $2.29M.
Hutchin Hill Capital first reported a position in Syneron Medical Ltd in Q1 2015 and held it in 3 quarters.
Hutchin Hill Capital's Syneron Medical Ltd position peaked at $2.29M in Q1 2017.
79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Hutchin Hill Capital's 13F filing for Q2 2017, filed 14 Aug 2017.